User profiles for "author:M De Bruin"
Marijn de BruinProfessor Health psychology Verified email at radboudumc.nl Cited by 6972 |
Behavior change techniques and their mechanisms of action: a synthesis of links described in published intervention literature
Background Despite advances in behavioral science, there is no widely shared
understanding of the “mechanisms of action”(MoAs) through which individual behavior …
understanding of the “mechanisms of action”(MoAs) through which individual behavior …
[HTML][HTML] Epidemiology of adverse drug reactions in Europe: a review of recent observational studies
JC Bouvy, ML De Bruin, MA Koopmanschap - Drug safety, 2015 - Springer
Adverse drug reactions (ADRs) cause considerable mortality and morbidity but no recent
reviews are currently available for the European region. Therefore, we performed a review of …
reviews are currently available for the European region. Therefore, we performed a review of …
[HTML][HTML] A systematic review of hand hygiene improvement strategies: a behavioural approach
A Huis, T van Achterberg, M de Bruin, R Grol… - Implementation …, 2012 - Springer
Background Many strategies have been designed and evaluated to address the problem of
low hand hygiene (HH) compliance. Which of these strategies are most effective and how …
low hand hygiene (HH) compliance. Which of these strategies are most effective and how …
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
…, PWB Derksen, M de Bruin… - Proceedings of the …, 2008 - National Acad Sciences
Whereas target-specific drugs are available for treating ERBB2-overexpressing and
hormone receptor-positive breast cancers, no tailored therapy exists for hormone receptor …
hormone receptor-positive breast cancers, no tailored therapy exists for hormone receptor …
Prolonged QTc interval and risk of sudden cardiac death in a population of older adults
SMJM Straus, JA Kors, ML De Bruin… - Journal of the American …, 2006 - jacc.org
Objectives: This study sought to investigate whether prolongation of the heart rate-corrected
QT (QTc) interval is a risk factor for sudden cardiac death in the general population …
QT (QTc) interval is a risk factor for sudden cardiac death in the general population …
Late cardiotoxicity after treatment for Hodgkin lymphoma
BMP Aleman, AW van den Belt-Dusebout, ML De Bruin… - Blood, 2007 - ashpublications.org
We assessed cardiovascular disease (CVD) incidence in 1474 survivors of Hodgkin
lymphoma (HL) younger than 41 years at treatment (1965-1995). Multivariable Cox …
lymphoma (HL) younger than 41 years at treatment (1965-1995). Multivariable Cox …
Clinical effectiveness of attentional bias modification training in abstinent alcoholic patients
TM Schoenmakers, M de Bruin, IFM Lux… - Drug and alcohol …, 2010 - Elsevier
A new training to decrease attentional bias (attentional bias modification training, ABM) was
tested in a randomized controlled experimental study with alcohol-dependent patients as an …
tested in a randomized controlled experimental study with alcohol-dependent patients as an …
Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes
ML De Bruin, J Sparidans, MB van't Veer… - Journal of Clinical …, 2009 - ascopubs.org
Purpose We assessed the long-term risk of breast cancer (BC) after treatment for Hodgkin's
lymphoma (HL). We focused on the volume of breast tissue exposed to radiation and the …
lymphoma (HL). We focused on the volume of breast tissue exposed to radiation and the …
From theory-inspired to theory-based interventions: a protocol for developing and testing a methodology for linking behaviour change techniques to theoretical …
Background Understanding links between behaviour change techniques (BCTs) and
mechanisms of action (the processes through which they affect behaviour) helps inform the …
mechanisms of action (the processes through which they affect behaviour) helps inform the …
Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin
B Evers, R Drost, E Schut, M de Bruin… - Clinical Cancer …, 2008 - AACR
Purpose: To assess efficacy of the novel, selective poly (ADP-ribose) polymerase-1 (PARP-
1) inhibitor AZD2281 against newly established BRCA2-deficient mouse mammary tumor …
1) inhibitor AZD2281 against newly established BRCA2-deficient mouse mammary tumor …